The aforementioned studies demonstrated that USP7 acted as a Dub for BCR-ABL ubiquitination and a regulator of BCR-ABL-related oncogenic signaling pathways, suggesting USP7 might promote CML cell survival. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.